Trying to conceive · 5 min · sourced

What basal body temperature can't tell you about your fertility — and what tests actually can

Published · Updated · Not medical advice

Basal body temperature confirms ovulation has occurred, but it doesn't predict when you'll ovulate, assess egg quality, reveal tubal blockages, evaluate sperm health, or measure progesterone levels. A comprehensive fertility evaluation includes ovarian reserve testing (AMH, antral follicle count), tubal patency assessment (hysterosalpingography or ultrasound), semen analysis, and mid-luteal progesterone measurement. These tests identify the treatable causes of infertility — blocked tubes, low sperm count, inadequate progesterone — that BBT tracking alone will never detect.

What BBT actually tells you — and what it doesn't

BBT confirms a temperature rise occurred after ovulation, indicating a corpus luteum formed and progesterone is being released. That temperature shift shows ovulation happened — past tense. By the time your temperature goes up, the fertile window has closed.

In one small study of 30 normally menstruating women, a biphasic chart matched an ovulatory hormonal pattern in most cycles, but about 20% of ovulatory cycles showed a flat (monophasic) chart, so a biphasic chart suggests ovulation but a flat one doesn't rule it out1. BBT is only one piece of the fertility picture. BBT cannot predict when ovulation will happen, so it's not useful for timing intercourse in the current cycle.

The temperature rise tells you nothing about whether the egg released is healthy, whether your fallopian tubes are open, whether sperm can reach the egg, or whether your uterine lining is receptive.

Why BBT can't assess egg quality or ovarian reserve

BBT confirms an egg was released, but tells you nothing about that egg's quality or chromosomal health. A 2022 review notes that age is still the strongest driver of success rates with fertility treatments, while AMH reflects egg quantity but not egg health or chances of conception2.

Fertility testing for the female partner focuses on ovarian reserve, ovulatory function, and structural abnormalities, and imaging can be used to assess ovarian reserve3. Anti-Müllerian hormone testing estimates ovarian reserve, but it reflects the quantity of oocytes rather than their health or the chances of conception2.

What BBT misses about the path to conception

Tubal patency is one of the key components of a female infertility workup, since structural abnormalities such as tubal problems can contribute to infertility3. BBT provides no information about tubal patency. Even with confirmed ovulation, if one or both tubes are blocked, sperm and egg cannot meet.

Male factor contributes to roughly half of infertility cases3. Semen analysis evaluates sperm concentration, motility, and morphology. Male factor is a cause of infertility in 40-50% of couples, which is why a semen analysis is recommended from the outset of an infertility workup3. BBT tells you nothing about sperm health.

ACOG and ASRM recommend fertility evaluation after 12 months of trying if you're under 35, or after 6 months if you're 35 or older. If you have known risk factors — irregular cycles, history of pelvic infection, endometriosis, prior pelvic or abdominal surgery — start evaluation sooner regardless of age.

Many couples with confirmed ovulation, open tubes, and normal semen still fail to conceive — a category called unexplained infertility3. This proves that ovulation alone is necessary but not sufficient.

BBT and luteal phase quality — what the temperature rise does and doesn't reveal

The temperature rise confirms progesterone is being produced after ovulation.

In one small study of 30 women, BBT and hormonal assays identified a deficient luteal phase in one woman, though BBT also missed ovulation in about 20% of ovulatory cycles1. Hormonal assays directly measure progesterone levels rather than inferring them from temperature.

Why BBT can't help you time intercourse prospectively

BBT only rises after the fertile window has closed.

Cervical mucus becomes clear, stretchy, and abundant in the days before ovulation. Cervical mucus gives you prospective information.

BBT is useful for confirming ovulation happened, but it's a retrospective tool.

What a comprehensive fertility evaluation includes

Sokkai provides guidance matched to your specific phase — not generic lifestyle advice. See how Sokkai works →

Ovarian reserve testing assesses egg quantity through blood tests on specific cycle days and an ultrasound to count developing follicles. These tests tell you how many eggs remain and how your ovaries are likely to respond to stimulation if you need fertility treatment.

Tubal patency assessment confirms your fallopian tubes are open. Hysterosalpingography (HSG) is an X-ray procedure where contrast dye is injected through the cervix and tracked as it fills the uterus and spills through the tubes.

Semen analysis evaluates sperm concentration, motility, and morphology.

When to move beyond BBT and start testing

BBT can be part of the picture when you see your doctor. Bringing your charts to your first appointment shows ovulation is happening and provides useful cycle-length data. But it's not a substitute for testing. The standard fertility workup addresses all the factors BBT can't assess: egg reserve, tubal patency, sperm health, and hormonal adequacy.

Women with perfect BBT charts still need comprehensive evaluation if conception hasn't happened within the recommended timeframe.

When to see a doctor

Seek medical evaluation if you've been trying to conceive for 12 months without success (or 6 months if you're 35 or older). But some situations warrant earlier assessment. See a doctor sooner if your cycles are irregular or absent, if you have severe pelvic pain or a history of pelvic infection or sexually transmitted infection, if you've had prior pelvic or abdominal surgery, if you have known or suspected endometriosis, or if your male partner has a history of fertility concerns or prior treatment. If you've been tracking BBT and confirmed ovulation but conception hasn't occurred within the recommended timeframe, a comprehensive workup is the next step.

What we don't know yet

AMH is a good marker of egg quantity (ovarian reserve) but does not reflect egg health or the chances of conception2.

Unexplained infertility — diagnosed when all standard testing is normal but conception doesn't occur — affects up to 30% of infertile couples3. We don't fully understand why ovulation, tubal patency, and normal semen analysis are sometimes not enough.

Every two weeks · English

More trying to conceive articles — delivered.

Same rhythm, same standards, in your inbox.

Get guidance matched to your phase, not generic advice

Sokkai's AI coach knows where you are in the transition and adapts its guidance to your actual pattern — not a one-size-fits-all plan. Join the waitlist for early access.

Join the Sokkai waitlist
Track your symptoms with SokkaiGet the app →